In simple terms, PEMF is a noninvasive treatment that uses gentle electromagnetic pulses to stimulate your body at a cellular ...

If you live with Crohn’s disease, you’re already familiar with the incessant fatigue, abdominal pain, and diarrhea that comes along with a Crohn’s diagnosis. Crohn’s is an autoimmune disorder that ...

Streamlined pharmacologic recommendations challenge the stepwise approach for moderately to severely active disease.

The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease. The new guideline ...

Crohn disease is characterized by periods of clinical remission alternating with periods of recurrence. Persistent inflammation can lead to complications that include strictures, fistulas, abscesses, ...

Mirikizumab (Omvoh) improved outcomes in patients with moderately-to-severely active Crohn's disease with previous failure to standard therapy, a phase III randomized trial showed. Among over 1,000 ...

Patients with Crohn's disease and type 2 diabetes (T2D) had an increased use of corticosteroids, higher incidence of abdominal surgery, and decreased utilisation of certain advanced therapies compared ...